Copyright (c) 2024 Revista médico científica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
INTRODUCTION. The Pandemic of the Acquired Immune Deficiency Syndrome opened a new era in the history of tuberculosis. It’s the leading cause of death among people living with the Human Immunodeficiency Virus.
OBJECTIVES. To determine the prevalence of pulmonary tuberculosis and tuberculosis with extrapulmonary affection, in patients with tuberculosis living with Human Immune Deficiency Virus treated at the infectious diseases ward of the Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid.
MATERIALS AND METHODS. We performed a retrospective and descriptive study. We analyzed the medical records of patients with tuberculosis and living with Human Immune Deficiency Virus treated at the infectious diseases ward of the Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid from 2007 to 2010. We classified the types of clinical presentation of tuberculosis in: pulmonary and with extrapulmonary affection, the latter including extrapulmonary, disseminated and mixed. We compared clinical and laboratory variables between the types of clinical presentation.
RESULTS. We identified 147 patients. The prevalence of tuberculosis with extrapulmonary affection was 51.7%. The clinical presentation of disseminated tuberculosis had the lowest median of CD4 lymphocyte count and the highest lethality rate. 6.5% of the patients had an undetectable viral load. The 44.2% of the patients had at least one opportunistic infection; disseminated histoplasmosis was the most frequent. The lethality rate was 27.2%.
CONCLUSIONS. The prevalence rate of the clinical presentation of tuberculosis with extrapulmonary affection was 51.7%.
